Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2014 · 10-Q
Revenue$5.08B$5.08B+5.7% vs Q3 2013 Net Income$538.00M$538.00M−44.3% vs Q3 2013 EPS Diluted$0.36$0.36−41.0% vs Q3 2013 Gross Profit$2,628,000,000+8.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,201,000,000+130.1% Free Cash Flowderived$924,000,000+277.1% Margins · derivedGross margin51.7%+1.4 pt vs Q3 2013
Operating margin14.3%+4.5 pt vs Q3 2013
Net margin10.6%−9.5 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 6, 2014 · 37 d after period end